The Japanese market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of AV access thrombosis, PADVTECAD, and AIS.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for clot management devices in Japan across a 10-year period.


Expansion of endovascular clot management procedure volumes hinges on obtaining conclusive evidence demonstrating the comparative efficacy of these procedures over the current standard of care. 

What factors will limit immediate growth?

Which segments will benefit the most from emerging clinical evidence and to what extent?

How will the expanding use of novel oral anticoagulants affect clot management procedures?

How much influence will the well-established health care facilities have over clot management procedures in Japan?

Some large clinical trials have failed to show a benefit for endovascular clot management.

How will negative results of the ATTRACT trial impact clot management procedures in the VTE indication?

Will the data from the ATTRACT trial have an impact on the overall clot management device market?

How will the negative results of the TOTAL trial impact clot management procedures in the coronary indication?

Will the data from the TOTAL trial have an impact on the overall clot management device market?

A recent influx of clinical data supporting the effectiveness of neurovascular thrombectomy procedures for the treatment of ischemic stroke will fuel this market segment.

What factors limit growth of this rapidly expanding market?

What impact have recent product launches and clinical trials had on the market for neurovascular thrombectomy devices?

What strategies can device manufacturers in this space implement in order to gain a competitive advantage in this fast-growing market?

Many segments in the Japanese clot management device market will see reimbursement declines through 2026.

Which segments will have major reimbursement price declines and which segments will see little or no decline during the forecast period?

What factors will influence reimbursement declines for different segments?

Table of contents

  • Japan
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Key Report Updates
      • Average Currency Exchange Rates
      • Procedures Covered
      • Products Covered
    • Version History
    • Clot Management Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
        • Domestic Competitors
        • Physician Training and Marketing
        • Pricing Strategies and Purchasing Options
        • Regulatory Environment
      • Market Developments
    • Percutaneous Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Clinical Data
        • Product Improvements and Innovations
    • Embolectomy Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Catheter-Directed Thrombolysis Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Competitors
      • Competitive Factors and Strategies
    • Inferior Vena Cava Filter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Neurovascular Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Improvements and Innovations
        • Physician Training and Marketing
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Shruthi Narendranath, MSc

Shruthi Narendranath is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in heart valve and periphral vascular device markets. Shruthi holds a Master's degree in Bioinformatics from Cardiff University.  


Related Reports

Clot Management Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for clot management devices is characterized by a combination of rapidly expanding and relatively mature market segments, where device adoption hinges largely on positive cli...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Europe

The European market for clot management devices consists of a combination of rapidly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatmen...

View Details

Clot Management Devices | Medtech 360 | Market Insights | United States

The US market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatmen...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the tre...

View Details